FDA Orange Book · active-ingredient family
Clobetasol propionate
Clobetasol propionate is approved as 13 brand and 87 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:BYQLOVI · NDA 218158
13
Brand (NDA)
87
Generics (ANDA)
8
Listed patents
1
Exclusivity periods
Brand (NDA) products · aerosol, foam, cream, gel, lotion, ointment, shampoo, solution, spray, suspension/drops
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| BYQLOVIRLD | HARROW EYE | NDA 218158 | — | Mar 04, 2024 | |
| IMPEKLORLD | PHARMOBEDIENT | NDA 213691 | — | May 19, 2020 | |
| IMPOYZRLD | PRIMUS PHARMS | NDA 209483 | — | Nov 28, 2017 | |
| OLUX ERLD | PHARMOBEDIENT | NDA 022013 | — | Jan 12, 2007 | |
| CLOBEXRLD | GALDERMA LABS LP | NDA 021835 | AT | Oct 27, 2005 | |
| CLOBEXRLD | GALDERMA LABS | NDA 021644 | AB | Feb 05, 2004 | |
| CLOBEXRLD | GALDERMA LABS LP | NDA 021535 | AB | Jul 24, 2003 | |
| OLUXRLD | PHARMOBEDIENT | NDA 021142 | — | May 26, 2000 | |
| TEMOVATE ERLD | FOUGERA PHARMS | NDA 020340 | — | Jun 17, 1994 | |
| TEMOVATERLD | FOUGERA PHARMS | NDA 020337 | — | Apr 29, 1994 | |
| TEMOVATERLD | FOUGERA PHARMS | NDA 019966 | — | Feb 22, 1990 | |
| TEMOVATERLD | FOUGERA PHARMS | NDA 019322 | — | Dec 27, 1985 | |
| TEMOVATERLD | FOUGERA PHARMS | NDA 019323 | — | Dec 27, 1985 |
Generic (ANDA) products (87)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CLOBETASOL PROPIONATE | XIROMED | ANDA 210638 | AB1 | Nov 20, 2025 | |
| CLOBETASOL PROPIONATE | MACLEODS PHARMS LTD | ANDA 214345 | — | Dec 02, 2024 | |
| CLOBETASOL PROPIONATE | TARO | ANDA 208563 | — | Mar 14, 2024 | |
| CLOBETASOL PROPIONATE | MACLEODS PHARMS LTD | ANDA 215990 | AB | Dec 28, 2023 | |
| CLOBETASOL PROPIONATE | ALEMBIC | ANDA 215838 | AB1 | Apr 21, 2022 | |
| CLOBETASOL PROPIONATE | QUAGEN | ANDA 211240 | AT | Feb 17, 2022 | |
| CLOBETASOL PROPIONATE | AMNEAL | ANDA 214895 | AB | Jun 14, 2021 | |
| CLOBETASOL PROPIONATE | CHARTWELL RX | ANDA 211207 | — | Mar 26, 2021 | |
| CLOBETASOL PROPIONATE | SUN PHARMA CANADA | ANDA 214867 | AB | Mar 25, 2021 | |
| CLOBETASOL PROPIONATE | PRINSTON INC | ANDA 213139 | — | Feb 08, 2021 | |
| CLOBETASOL PROPIONATE | ENCUBE | ANDA 212982 | AB1 | Aug 28, 2020 | |
| CLOBETASOL PROPIONATE | ALEMBIC | ANDA 213290 | AB | May 18, 2020 | |
| CLOBETASOL PROPIONATE | ALEMBIC | ANDA 213291 | AB1 | Jan 27, 2020 | |
| CLOBETASOL PROPIONATE | TORRENT | ANDA 211836 | AB1 | Dec 30, 2019 | |
| CLOBETASOL PROPIONATE | ENCUBE | ANDA 211295 | AB | Nov 15, 2019 | |
| CLOBETASOL PROPIONATE | TORRENT | ANDA 212926 | — | Oct 25, 2019 | |
| CLOBETASOL PROPIONATE | ALEMBIC | ANDA 212881 | AT | Oct 21, 2019 | |
| CLOBETASOL PROPIONATE | SAPTALIS PHARMS | ANDA 211494 | AT | Oct 02, 2019 | |
| CLOBETASOL PROPIONATE | ALEMBIC | ANDA 211191 | AT | Oct 02, 2019 | |
| CLOBETASOL PROPIONATE | ZYDUS LIFESCIENCES | ANDA 205249 | AB | Sep 24, 2019 | |
| CLOBETASOL PROPIONATE | GLENMARK PHARMS LTD | ANDA 211450 | AB2 | Sep 09, 2019 | |
| CLOBETASOL PROPIONATE | ALEMBIC | ANDA 211800 | AB | Mar 04, 2019 | |
| CLOBETASOL PROPIONATE | GLENMARK PHARMS LTD | ANDA 210809 | AB1 | Feb 15, 2019 | |
| CLOBETASOL PROPIONATE | PAI HOLDINGS PHARM | ANDA 208589 | — | Jan 23, 2019 | |
| CLOBETASOL PROPIONATE | RISING | ANDA 211401 | AB1 | Jan 11, 2019 | |
| CLOBETASOL PROPIONATE | AMNEAL | ANDA 211256 | AB1 | Dec 26, 2018 | |
| CLOBETASOL PROPIONATE | EPIC PHARMA LLC | ANDA 211348 | — | Oct 26, 2018 | |
| CLOBETASOL PROPIONATE | ZYDUS PHARMS | ANDA 211074 | AB1 | Oct 15, 2018 | |
| CLOBETASOL PROPIONATE | TARO | ANDA 208779 | AB1 | Oct 04, 2018 | |
| CLOBETASOL PROPIONATE | AMNEAL | ANDA 210551 | — | Aug 21, 2018 | |
| CLOBETASOL PROPIONATE | XIROMED | ANDA 210034 | AB1 | Jun 15, 2018 | |
| CLOBETASOL PROPIONATE | GLENMARK SPECLT | ANDA 209095 | — | May 10, 2018 | |
| CLOBETASOL PROPIONATE | NOVEL LABS INC | ANDA 208841 | AB | May 04, 2018 | |
| CLOBETASOL PROPIONATE | GLENMARK PHARMS LTD | ANDA 210190 | — | Apr 18, 2018 | |
| CLOBETASOL PROPIONATE | PAI HOLDINGS PHARM | ANDA 209974 | — | Apr 17, 2018 | |
| CLOBETASOL PROPIONATE | XIROMED | ANDA 209701 | AB | Apr 17, 2018 | |
| CLOBETASOL PROPIONATE | APOTEX | ANDA 210446 | — | Apr 17, 2018 | |
| CLOBETASOL PROPIONATE | GLENMARK SPECLT | ANDA 209004 | — | Mar 26, 2018 | |
| CLOBETASOL PROPIONATE | LUPIN | ANDA 208125 | — | Mar 26, 2018 | |
| CLOBETASOL PROPIONATE | SUN PHARMA CANADA | ANDA 208842 | AT | Mar 26, 2018 | |
| CLOBETASOL PROPIONATE | LUPIN | ANDA 210208 | AB1 | Jan 30, 2018 | |
| CLOBETASOL PROPIONATE | ZYDUS PHARMS | ANDA 210199 | AB | Oct 27, 2017 | |
| CLOBETASOL PROPIONATE | HIKMA | ANDA 209871 | — | Oct 27, 2017 | |
| CLOBETASOL PROPIONATE | MACLEODS PHARMS LTD | ANDA 209361 | AT | Oct 25, 2017 | |
| CLOBETASOL PROPIONATE | LUPIN | ANDA 209147 | AB | Sep 22, 2017 | |
| CLOBETASOL PROPIONATE (EMOLLIENT) | BEACH PRODS | ANDA 209411 | AB2 | Aug 21, 2017 | |
| CLOBETASOL PROPIONATE | INGENUS PHARMS LLC | ANDA 206805 | — | Jul 31, 2017 | |
| CLOBETASOL PROPIONATE | SCIEGEN PHARMS | ANDA 207218 | — | Apr 28, 2017 | |
| CLOBETASOL PROPIONATE | GLENMARK SPECLT | ANDA 208933 | — | Mar 20, 2017 | |
| CLOBETASOL PROPIONATE | ENCUBE | ANDA 208881 | — | Mar 06, 2017 | |
| CLOBETASOL PROPIONATE | ZYDUS PHARMS | ANDA 206378 | AT | Feb 16, 2017 | |
| CLOBETASOL PROPIONATE | BEACH PRODS | ANDA 208667 | — | Nov 29, 2016 | |
| CLOBETASOL PROPIONATE | NOVEL LABS INC | ANDA 206075 | AT | Nov 23, 2015 | |
| CLOBETASOL PROPIONATE | PADAGIS ISRAEL | ANDA 201402 | AB2 | Aug 14, 2012 | |
| CLOBETASOL PROPIONATE | PADAGIS ISRAEL | ANDA 090974 | AB | Aug 09, 2012 | |
| CLOBETASOL PROPIONATE | SUN PHARMA CANADA | ANDA 200302 | AB | Jul 02, 2012 | |
| CLOBETASOL PROPIONATE | PADAGIS US | ANDA 090898 | — | Jun 16, 2011 | |
| CLOBETASOL PROPIONATE | ACTAVIS MID ATLANTIC | ANDA 078854 | — | Jun 07, 2011 | |
| CLOBETASOL PROPIONATE | ACTAVIS MID ATLANTIC | ANDA 078223 | AB | Dec 04, 2008 | |
| CLOBETASOL PROPIONATE | PADAGIS ISRAEL | ANDA 077763 | AB1 | Mar 10, 2008 | |
| CLOBETASOL PROPIONATE | ENCUBE | ANDA 076977 | AT | Aug 05, 2005 | |
| EMBELINE | HIKMA | ANDA 076141 | — | Apr 12, 2002 | |
| CLOBETASOL PROPIONATE (EMOLLIENT) | ANI PHARMS | ANDA 075733 | — | Aug 22, 2001 | |
| CLOBETASOL PROPIONATE | AUROBINDO PHARMA USA | ANDA 075338 | AB1 | Feb 09, 2001 | |
| CLOBETASOL PROPIONATE | SUN PHARMA CANADA | ANDA 075363 | — | Dec 29, 2000 | |
| CLOBETASOL PROPIONATE (EMOLLIENT) | SUN PHARMA CANADA | ANDA 075633 | AB2 | May 17, 2000 | |
| CLOBETASOL PROPIONATE | FOUGERA PHARMS | ANDA 075368 | AB | Feb 15, 2000 | |
| CLOBETASOL PROPIONATE | SUN PHARMA CANADA | ANDA 075279 | AB | May 28, 1999 | |
| CLOBETASOL PROPIONATE (EMOLLIENT) | FOUGERA PHARMS | ANDA 075430 | AB2 | May 26, 1999 | |
| CLOBETASOL PROPIONATE | FOUGERA PHARMS | ANDA 075391 | AT | Feb 08, 1999 | |
| EMBELINE E | HIKMA | ANDA 075325 | — | Dec 24, 1998 | |
| CLOBETASOL PROPIONATE | SUN PHARMA CANADA | ANDA 075224 | AT | Nov 16, 1998 | |
| CLOBETASOL PROPIONATE | WOCKHARDT BIO AG | ANDA 075205 | — | Nov 13, 1998 | |
| CLOBETASOL PROPIONATE | AUROBINDO PHARMA USA | ANDA 075057 | AB | Aug 12, 1998 | |
| CLOBETASOL PROPIONATE | PADAGIS US | ANDA 075027 | AB | Oct 31, 1997 | |
| CORMAX | HIKMA | ANDA 074220 | — | May 16, 1997 | |
| CLOBETASOL PROPIONATE | FOUGERA PHARMS INC | ANDA 074392 | AB1 | Sep 30, 1996 | |
| CLOBETASOL PROPIONATE | SUN PHARMA CANADA | ANDA 074248 | AB | Jul 12, 1996 | |
| CLOBETASOL PROPIONATE | SUN PHARMA CANADA | ANDA 074249 | AB1 | Jul 08, 1996 | |
| CLOBETASOL PROPIONATE | FOUGERA PHARMS | ANDA 074407 | AB | Feb 23, 1996 | |
| CLOBETASOL PROPIONATE | COSETTE | ANDA 074331 | — | Dec 15, 1995 | |
| EMBELINE | HIKMA | ANDA 074222 | — | Dec 06, 1995 | |
| EMBELINE | HIKMA | ANDA 074221 | — | Mar 31, 1995 | |
| CLOBETASOL PROPIONATE | COSETTE | ANDA 074139 | — | Aug 03, 1994 | |
| CLOBETASOL PROPIONATE | ACTAVIS MID ATLANTIC | ANDA 074128 | — | Aug 03, 1994 | |
| CLOBETASOL PROPIONATE | TEVA PHARMS USA | ANDA 074087 | — | Feb 16, 1994 | |
| CLOBETASOL PROPIONATE | COSETTE PHARMS NC | ANDA 074089 | AB | Feb 16, 1994 |
Marketing exclusivity (1)
- NPNew product exclusivity (3 years)
Mar 04, 2027
in 9 mo
Listed patents (8)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8460641 | Nov 05, 2028 | in 2 yr 5 mo | ProductU-1410 |
| 10064875 | Aug 31, 2030 | in 4 yr 3 mo | ProductU-88 |
| 9956231 | Aug 31, 2030 | in 4 yr 3 mo | ProductU-88 |
| 11179465 | Aug 31, 2030 | in 4 yr 3 mo | ProductU-1858 |
| 10588914 | Aug 31, 2030 | in 4 yr 3 mo | ProductU-2771 |
| 9855334 | Mar 11, 2035 | in 8 yr 10 mo | Product |
| 11376262 | May 09, 2036 | in 10 yr | ProductU-19 |
| 10588913 | May 09, 2036 | in 10 yr | Product |
Clobetasol propionate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

